Diaphragm pacing system receives FDA approval for use with ALS patients

An electronic system that stimulates the nerve of the diaphragm muscles has received approval from the Food and Drug Administration (FDA) for use in patients with Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease. The system called NeuRx Diaphragm Pacing System (DPS) will help ALS patients breathe longer without the aid of a ventilator.

Read the whole article on Physorg

More from Physorg